Clinical trials
Phase 3 Small Cell Lung Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 10 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
| Completed | 13 |
| Active, not recruiting | 11 |
| Unknown status | 6 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| Chinese Academy of Medical Sciences | 2 |
| Hoffmann-La Roche | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Luye Pharma Group Ltd. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Shanghai Junshi Bioscience Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 49 |
| Lung Neoplasms | 3 |
| Brain Neoplasms | 2 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Esophagitis | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.